Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Total Current Liabilities: 2016-2019

Historic Total Current Liabilities for Monopar Therapeutics (MNPR) over the last 4 years, with Dec 2019 value amounting to $724,165.

  • Monopar Therapeutics' Total Current Liabilities rose 26.09% to $609,840 in Q3 2020 from the same period last year, while for Sep 2020 it was $609,840, marking a year-over-year increase of 26.09%. This contributed to the annual value of $724,165 for FY2019, which is 81.24% up from last year.
  • According to the latest figures from FY2019, Monopar Therapeutics' Total Current Liabilities is $724,165, which was up 81.24% from $399,551 recorded in FY2018.
  • In the past 5 years, Monopar Therapeutics' Total Current Liabilities registered a high of $724,165 during FY2019, and its lowest value of $64,510 during FY2016.
  • Moreover, its 3-year median value for Total Current Liabilities was $399,551 (2018), whereas its average is $478,528.
  • Data for Monopar Therapeutics' Total Current Liabilities shows a peak YoY spiked of 383.44% (in 2017) over the last 5 years.
  • Yearly analysis of 4 years shows Monopar Therapeutics' Total Current Liabilities stood at $64,510 in 2016, then spiked by 383.44% to $311,867 in 2017, then grew by 28.12% to $399,551 in 2018, then skyrocketed by 81.24% to $724,165 in 2019.